Annual CFO
-$25.81 M
+$23.90 M+48.08%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual cash flow from operations is -$25.81 million, with the most recent change of +$23.90 million (+48.08%) on March 31, 2024.
- During the last 3 years, VTGN annual CFO has fallen by -$13.74 million (-113.80%).
- VTGN annual CFO is now -374001.45% below its all-time high of -$6900.00, reached on December 31, 2010.
Performance
VTGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$10.89 M
-$17.00 K-0.16%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly cash flow from operations is -$10.89 million, with the most recent change of -$17.00 thousand (-0.16%) on September 30, 2024.
- Over the past year, VTGN quarterly CFO has stayed the same.
- VTGN quarterly CFO is now -1184.59% below its all-time high of $1.00 million, reached on September 30, 2020.
Performance
VTGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$33.49 M
-$4.70 M-16.31%
September 30, 2024
Summary
- As of February 8, 2025, VTGN TTM cash flow from operations is -$33.49 million, with the most recent change of -$4.70 million (-16.31%) on September 30, 2024.
- Over the past year, VTGN TTM CFO has stayed the same.
- VTGN TTM CFO is now -11162233.33% below its all-time high of -$300.00, reached on March 31, 2008.
Performance
VTGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VTGN Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +48.1% | 0.0% | 0.0% |
3 y3 years | -113.8% | 0.0% | 0.0% |
5 y5 years | -77.7% | 0.0% | 0.0% |
VTGN Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -113.8% | +48.1% | -140.1% | +33.4% | -29.7% | +44.1% |
5 y | 5-year | -113.8% | +48.1% | -1184.6% | +33.4% | -286.6% | +44.1% |
alltime | all time | <-9999.0% | +48.1% | -1184.6% | +33.4% | <-9999.0% | +44.1% |
VistaGen Therapeutics Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$10.89 M(+0.2%) | -$33.49 M(+16.3%) |
Jun 2024 | - | -$10.87 M(+51.0%) | -$28.79 M(+11.5%) |
Mar 2024 | -$25.81 M(-48.1%) | -$7.20 M(+58.7%) | -$25.81 M(-1.1%) |
Dec 2023 | - | -$4.53 M(-26.7%) | -$26.09 M(-17.1%) |
Sep 2023 | - | -$6.19 M(-21.6%) | -$31.49 M(-24.4%) |
Jun 2023 | - | -$7.89 M(+5.6%) | -$41.64 M(-16.2%) |
Mar 2023 | -$49.72 M(+9.9%) | -$7.47 M(-24.8%) | -$49.72 M(-14.0%) |
Dec 2022 | - | -$9.93 M(-39.2%) | -$57.83 M(-3.5%) |
Sep 2022 | - | -$16.34 M(+2.3%) | -$59.94 M(+8.9%) |
Jun 2022 | - | -$15.97 M(+2.4%) | -$55.05 M(+21.6%) |
Mar 2022 | -$45.26 M(+274.8%) | -$15.59 M(+29.4%) | -$45.26 M(+29.5%) |
Dec 2021 | - | -$12.05 M(+5.2%) | -$34.95 M(+25.3%) |
Sep 2021 | - | -$11.45 M(+85.5%) | -$27.89 M(+80.7%) |
Jun 2021 | - | -$6.17 M(+16.9%) | -$15.44 M(+27.9%) |
Mar 2021 | -$12.07 M(-23.4%) | -$5.28 M(+5.9%) | -$12.07 M(+28.8%) |
Dec 2020 | - | -$4.99 M(-597.0%) | -$9.37 M(+8.2%) |
Sep 2020 | - | $1.00 M(-135.8%) | -$8.66 M(-37.2%) |
Jun 2020 | - | -$2.81 M(+8.8%) | -$13.80 M(-12.4%) |
Mar 2020 | -$15.76 M(+8.5%) | -$2.58 M(-39.7%) | -$15.76 M(-5.8%) |
Dec 2019 | - | -$4.28 M(+3.5%) | -$16.73 M(+2.3%) |
Sep 2019 | - | -$4.14 M(-13.1%) | -$16.36 M(+1.3%) |
Jun 2019 | - | -$4.76 M(+33.9%) | -$16.15 M(+11.2%) |
Mar 2019 | -$14.53 M(+60.4%) | -$3.56 M(-9.0%) | -$14.53 M(+7.0%) |
Dec 2018 | - | -$3.91 M(-0.5%) | -$13.57 M(+12.1%) |
Sep 2018 | - | -$3.93 M(+25.3%) | -$12.11 M(+20.4%) |
Jun 2018 | - | -$3.14 M(+20.4%) | -$10.06 M(+11.1%) |
Mar 2018 | -$9.06 M(+24.7%) | -$2.60 M(+6.5%) | -$9.06 M(+16.9%) |
Dec 2017 | - | -$2.44 M(+30.3%) | -$7.75 M(+4.7%) |
Sep 2017 | - | -$1.88 M(-12.1%) | -$7.40 M(-4.2%) |
Jun 2017 | - | -$2.13 M(+64.9%) | -$7.73 M(+6.4%) |
Mar 2017 | -$7.26 M(+51.0%) | -$1.29 M(-38.2%) | -$7.26 M(-0.2%) |
Dec 2016 | - | -$2.10 M(-4.9%) | -$7.28 M(+14.6%) |
Sep 2016 | - | -$2.20 M(+31.8%) | -$6.35 M(+12.3%) |
Jun 2016 | - | -$1.67 M(+27.6%) | -$5.66 M(+17.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | -$4.81 M(+73.7%) | -$1.31 M(+12.0%) | -$4.81 M(+9.4%) |
Dec 2015 | - | -$1.17 M(-22.4%) | -$4.39 M(+23.2%) |
Sep 2015 | - | -$1.51 M(+82.9%) | -$3.56 M(+38.2%) |
Jun 2015 | - | -$823.30 K(-8.0%) | -$2.58 M(-6.8%) |
Mar 2015 | -$2.77 M(+30.2%) | -$894.50 K(+162.3%) | -$2.77 M(+18.3%) |
Dec 2014 | - | -$341.00 K(-34.6%) | -$2.34 M(-0.1%) |
Sep 2014 | - | -$521.60 K(-48.4%) | -$2.34 M(-2.6%) |
Jun 2014 | - | -$1.01 M(+116.6%) | -$2.41 M(+13.2%) |
Mar 2014 | -$2.13 M(-38.6%) | -$467.10 K(+36.4%) | -$2.13 M(-19.1%) |
Dec 2013 | - | -$342.50 K(-41.4%) | -$2.63 M(-19.1%) |
Sep 2013 | - | -$584.60 K(-20.1%) | -$3.25 M(-16.7%) |
Jun 2013 | - | -$731.80 K(-24.6%) | -$3.90 M(+12.6%) |
Mar 2013 | -$3.46 M(-2.9%) | -$970.00 K(+0.8%) | -$3.46 M(+7.8%) |
Dec 2012 | - | -$962.60 K(-22.0%) | -$3.21 M(-2.9%) |
Sep 2012 | - | -$1.23 M(+316.7%) | -$3.31 M(+19.2%) |
Jun 2012 | - | -$296.20 K(-58.8%) | -$2.78 M(-22.2%) |
Mar 2012 | -$3.57 M(>+9900.0%) | -$718.60 K(-32.1%) | -$3.57 M(+25.2%) |
Dec 2011 | - | -$1.06 M(+50.7%) | -$2.85 M(+58.9%) |
Sep 2011 | - | -$702.20 K(-35.4%) | -$1.79 M(+64.4%) |
Jun 2011 | - | -$1.09 M(>+9900.0%) | -$1.09 M(>+9900.0%) |
Mar 2011 | - | -$1700.00(-19.0%) | -$8600.00(+24.6%) |
Dec 2010 | -$6900.00(-69.7%) | -$2100.00(+2000.0%) | -$6900.00(-5.5%) |
Sep 2010 | - | -$100.00(-97.9%) | -$7300.00(+1.4%) |
Jun 2010 | - | -$4700.00(<-9900.0%) | -$7200.00(+50.0%) |
Mar 2010 | - | $0.00(-100.0%) | -$4800.00(-78.9%) |
Dec 2009 | -$22.80 K(+58.3%) | -$2500.00(<-9900.0%) | -$22.80 K(-33.5%) |
Sep 2009 | - | $0.00(-100.0%) | -$34.30 K(-0.3%) |
Jun 2009 | - | -$2300.00(-87.2%) | -$34.40 K(+6.8%) |
Mar 2009 | - | -$18.00 K(+28.6%) | -$32.20 K(+122.1%) |
Dec 2008 | -$14.40 K | -$14.00 K(>+9900.0%) | -$14.50 K(+2800.0%) |
Sep 2008 | - | -$100.00(0.0%) | -$500.00(+25.0%) |
Jun 2008 | - | -$100.00(-66.7%) | -$400.00(+33.3%) |
Mar 2008 | - | -$300.00(-86.4%) | -$300.00(-86.4%) |
Mar 2007 | - | -$2200.00 | -$2200.00 |
FAQ
- What is VistaGen Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual CFO year-on-year change?
- What is VistaGen Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly CFO year-on-year change?
- What is VistaGen Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for VistaGen Therapeutics?
- What is VistaGen Therapeutics TTM CFO year-on-year change?
What is VistaGen Therapeutics annual cash flow from operations?
The current annual CFO of VTGN is -$25.81 M
What is the all time high annual CFO for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual cash flow from operations is -$6900.00
What is VistaGen Therapeutics annual CFO year-on-year change?
Over the past year, VTGN annual cash flow from operations has changed by +$23.90 M (+48.08%)
What is VistaGen Therapeutics quarterly cash flow from operations?
The current quarterly CFO of VTGN is -$10.89 M
What is the all time high quarterly CFO for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly cash flow from operations is $1.00 M
What is VistaGen Therapeutics quarterly CFO year-on-year change?
Over the past year, VTGN quarterly cash flow from operations has changed by $0.00 (0.00%)
What is VistaGen Therapeutics TTM cash flow from operations?
The current TTM CFO of VTGN is -$33.49 M
What is the all time high TTM CFO for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM cash flow from operations is -$300.00
What is VistaGen Therapeutics TTM CFO year-on-year change?
Over the past year, VTGN TTM cash flow from operations has changed by $0.00 (0.00%)